Review on: Pulsatile drug delivery systems

Journal of Pharmaceutical Sciences and Research

Volumn 1, Issue 4, 2009, Pages 109-115

  Ravi Kumar Reddy, J ^a   Veera Jyothsna, M ^b   Mohamed Saleem, T S ^a   Madhu Sudhana Chetty, C ^a  

^a ANNAMACHARYA COLLEGE OF PHARMACY   (India)

^b NONE

Author keywords

Lag time; Pulsatile drug release; Rupturable coating

Indexed keywords

ANTIHISTAMINIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DICLOFENAC; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOCORTICOID; GLYCERYL TRINITRATE; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; METHYLPHENIDATE; NONSTEROID ANTIINFLAMMATORY AGENT; POLY(N ISOPROPYLACRYLAMIDE); PROPRANOLOL; SULFONYLUREA; VERAPAMIL;

ARTHRITIS; ASTHMA; DIABETES MELLITUS; DRUG CAPSULE; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG SOLUBILITY; HUMAN; HYDROGEL; HYPERCHOLESTEROLEMIA; HYPERTENSION; MICELLE; OSMOSIS; PEPTIC ULCER; PULSATILE DRUG RELEASE; REVIEW; THERMAL STIMULATION;

EID: 77953373251     PISSN: None     EISSN: 09751459     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Bussemer, T., Otto, I., Bodmeier, R., Pulsatile drug-delivery systems, Crit. Rev. Ther. Drug Carrier Syst. 18 (5) (2001) 433-458.
2. Lemmer, B., Chronopharmacokinetics: implications for drug treatment, J. Pharm. Pharmacology, 51 (1999) 887-890.
3. Ritschel.,W.A., Forusz, H., Chronopharmacology: a review of drugs studies, Methods Find. Exp. Clin. Pharmacol. 16 (1) (1994) 57-75.
4. Peppas, N.A., Fundamentals on pH- and temperature-sensitive delivery systems, Pulsatile Drug Delivery, Wissenschaftliche Verlagsgesellschaft, Stuttgart, 1993, 41-56.
5. Baker, R.W., Controlled release delivery system by an osmotic bursting mechanism. US Patent 3,952,741, 1976.
6. Ueda, T., Hata, Yamaguchi, H., Kotani, M., Ueda, Y., Development of a novel drug release system, time-controlled explosion system (TES). I. Concept and design, J. Drug Target. 2 (1994) 35-44.
7. Schultz, P.A. Kleinebudde. P., New multiparticulate delayed release system. Part I: dissolution properties and release mechanism, J. Control. Release 47 (1997) 181-189.
8. Morita, R., Honda.,Y., Takahashi, R., Development of oral controlled release preparations, a PVA swelling controlled release system (SCRS). I. Design of SCRS and its release controlling factor, J. Control. Release 63 (2000) 279-304.
9. Caramella, P., Colombo,G. Bettinetti, F. Giordano, U. Conte, A.L. Manna, Swelling properties of disintegrants, Acta Pharm. Technol. 30 (2) (1984) 132-139.
10. Wan, L.S.C., Prasad, K.P.P., Comparison of the swelling character- istics of tablet disintegrations at the microscopic level, Acta Pharm. Technol. 36 (1990) 20-23.
11. Gennaro AR, ed. Remington: The Science and Practice of Pharmacy. 20th ed. USA: Lippincott, Williams & Wilkins; 2000; 20:903-905.
12. Das NG, Das SK. Controlled release of oral dosage forms, formulation, finish, and fill. 2003; 10-16.
13. Ashford M, Fell JT, Attwood D, Sharma H, Wood head PJ. Int J Pharm 1993a, 95: 193-199.
14. Evans., D.F, Pye G, Bramley R, Hardcastle JD. G.ut 1988, 29:1035-1041.
15. Gurny, R., Junginger, H.E. and Peppas, N., Eds., In; Pulsatile Drug Delivery: Current Application and Future Trends, Wissenschefliche Verlagsgesellschaft, Stuttgart, Germany, 1993.
16. Valentine CI, Richard AK & Abdul WB. Drug delivery to colon. The drug delivery componies report summer 2004.
17. Basit AW, Lacey LF. Int J Pharm 2001, 227: 157-165.
18. Takaya T, Ikada C, Imagawa N, Niwa K, Takada K. J Pharm Pharmacol 1995, 47:474-478.
19. Bussemer T, Otto I, Bodmeier R. Pulsatile drug delivery sysyems. Crit Rev The Drug Carrier System. 2001; 18(5):433-58. Review.
20. Wildind IR, Davis SS, Bakhshaee M, Stevens HNE, Sparrow RA, Brennan J Gastrointestinal transit and systemic absorption of captopril from a pulsed release formulation. Pharm Res. 1992; 9:654-657.
21. Saeger H, Virley P. Pulsincap& Mac226: Pulsed Release Dosage Form. Product information from Scherer DDS. Ltd; 2004.
22. Krögel I, Bodmeier R. Floating or pulsatile drug delivery systems based on coated effervescent cores. Int J Pharm. 1999; 187:175-184.
23. Amidon GL, Leesman GD. Pulsatile Drug Delivery System. US Patent No. 5,229,131; 1993.
24. Daumesnil R. Marketing Considerations for multiparticulate drug delivery systems. In: Ghebre-Sellassie I, ed. Multiparticulate Oral Drug Delivery. New York, NY: Marcel Dekker, Inc.; 1994:457-474.
25. Ueda Y, Hata T, Yamaguchi H, Ueda S, Kotani M. Time Controlled Explosion System and Process for Preparation for the Same. US Patent No. 4,871,549; 1989.
26. Ueda Y, Hata T, Yamaguchi H, Kotani M, Ueda S. Development of a novel drug release system, time-controlled explosion system (TES). Part 1: concept and design. J Drug Targeting. 1994; 2:35-44.
27. Schultz P, Tho I, Kleinebudde P. A new multiparticulate delayed release system. Part II: coating formulation and properties of free films. J Contr Rel. 1997; 47:191-199.
28. Chen C-M. Multiparticulate Pulsatile Drug Delivery System. US Patent No. 5,508,040; 1996.
29. Schultz P, Kleinebudde P. A new multiparticulate delayed release system. Part I: dissolution properties and release mechanism. J Contr Rel. 1997; 47:181-189.
30. Schultz P, Tho I, Kleinebudde P. A new multiparticulate delayed release system. Part II: coating formulation and properties of free films. J Contr Rel. 1997; 47:191-199.
31. Survase S, Kumar N. Pulsatile Drug Delivery: Current Scenario. CRIPS. 2007; 8(2): 27-33.